Novonix : OTCQX Best 50 Presentation

OTC Markets Conference

Important Notice and Disclaimers

The information contained in this presentation (the "Presentation") has been prepared by NOVONIX Limited (ACN 157 690 830) ("the Company" or "NOVONIX") solely for information purposes and the Company is solely responsible for the contents of this Presentation. It is intended to be a summary of certain information relating to the Company as at the date of the Presentation and does not purport to be a complete description of NOVONIX or contain all the information necessary to make an investment decision. Accordingly, this Presentation is not intended to, and should not, form the basis for any investment, divestment or other financial decision with respect to the Company. Any reproduction or distribution of the Presentation, in whole or in part, or the disclosure of its contents, without prior consent of the Company, is prohibited.

Not an Offer

This Presentation does not constitute, nor does it form part of an offer to sell or purchase, or the solicitation of an offer to sell or purchase, any securities of the Company. This Presentation may not be used in connection with any offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not permitted by law or in which the person making the offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such offer or solicitation. Any offering of securities will be made only by means of a registration statement (including a prospectus) filed with the U.S. Securities and Exchange Commission (the "SEC"), after such registration statement becomes effective, or pursuant to an exemption from, or in a transaction not subject to, the registration requirements under the U.S. Securities Act of 1933, as amended. No such registration statement has become effective, as of the date of this Presentation.

Forward-Looking Statements

This Presentation contains forward-looking statements about the Company and the industry in which it operates. Forward looking statements can generally be identified by use of words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," or "would," or other similar expressions. The Company has based such statements on its current expectations and projections about future events and trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Such forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company and/or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include, among others, regulatory developments in the United States, Australia and other jurisdictions, the continuation of the Company's partnership with the Research Group of Dr. Mark Obrovac at Dalhousie University for the development of the Company's technology, the Company's ability to scale-up production of its anode or cathode materials and the Company's ability to attract and retain key management and technology personnel. Forward-looking statements are not guarantees of future performance or outcomes and that actual performance and outcomes may differ materially from those made in or suggested by the forward-looking statements contained in this Presentation. Accordingly, recipients of this Presentation should not place undue reliance on forward looking statements. The Company disclaims any obligation to update any forward-looking statements made in this Presentation to reflect events or circumstances after its date or to reflect new information or the occurrence of unanticipated events, except as required by law.

Industry and Market Data

This Presentation contains estimates and information concerning our industry and our business, including estimated market size and projected growth rates of the markets for our products. Unless otherwise expressly stated, we obtained this industry, business, market, and other information from reports, research surveys, studies and similar data prepared by third parties, industry, and general publications, government data and similar sources. This Presentation also includes certain information and data that is derived from internal research. While we believe that our internal research is reliable, such research has not been verified by any third party.

Estimates and information concerning our industry and our business involve a number of assumptions and limitations. Although we are responsible for all of the disclosure contained in this Presentation and we believe the third-party market position, market opportunity and market size data included in this Presentation are reliable, we have not independently verified the accuracy or completeness of this third-party data. Information that is based on projections, assumptions and estimates of our future performance and the future performance of the industry in which we operate is necessarily subject to a high degree of uncertainty and risk due to a variety of factors, which could cause results to differ materially from those expressed in these publications and reports.

Trademarks, Service Marks and Trade Names

Throughout this Presentation, there are references to various trademarks, service marks and trade names that are used in the Company's business. "NOVONIX," the NOVONIX logo and other trademarks or service marks of NOVONIX appearing in this Presentation are the property of NOVONIX or its subsidiaries. Solely for convenience, the trademarks, service marks and trade names referred to in this Presentation are listed without the ® or ™ symbol, as applicable, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their right thereto. All other trademarks, trade names and service marks appearing in this Presentation are the property of their respective owners.

ASX: NVX Nasdaq: NVX OTCQX: NVNXF	2

TOC

TOC

• NOVONIX Introduction
• Summary of Recent Notable Announcements
• Phillips 66's Strategic Investment in NOVONIX
• Battery Materials Market and North American EV/ESS Industry Momentum
• NOVONIX Anode Materials
• NOVONIX Cathode Materials
• Conclusions

NOVONIX Investment Highlights

Our proprietary process technology and capabilities across the value chain drive innovation and commercial opportunities

We develop and supply industry leading battery testing equipment

We are a leading US-based battery materials and technology company with the first GWh-scale domestic supply agreement for synthetic graphite with KORE Power

Our offerings are directly compatible with today's installed and planned battery manufacturing technology

Demand for our technologies underpinned by exponential growth in EV sales and energy storage demand over the next decade and beyond

We have a clear path to profitability with global tier 1 customer base

Our leadership team is highly credentialed, continuing to successfully execute growth agenda

ASX: NVX Nasdaq: NVX OTCQX: NVNXF	3

Who We Are

NOVONIX is a battery materials and technology development company. We develop and supply what we believe to be the most accurate battery testing technology in the world. We are a leading US-based supplier with plans to scale significant domestic volumes of battery-grade synthetic graphite anode material.

bf

Better Performance, Longer Life, Lower Cost

		Leading US-based Supplier with
Most Accurate Battery Testing		Plans to Scale Significant		Developing New Applications
Technology		Domestic Volumes of Synthetic		and Partnerships
		Graphite Anode Material
				Cathode Materials

ASX: NVX Nasdaq: NVX OTCQX: NVNXF	4

Our Leadership and Board of Directors

Leadership Team

Dr. Chris Burns	Nick A. Liveris	Rashda Buttar	Suzanne Yeates	Danny Deas	Darcy Macdougald	Christopher York
Chief Executive Officer	Chief Financial Officer	Chief Legal and	Financial Controller and	President | NAM	President | BTS	Senior Vice President
		Administrative Officer	Co Secretary			Business Development

Scientific & Technical Advisors

Dr. Jeff Dahn	Dr. Mark Obrovac
Chief Scientific Advisor	Sponsored Researcher

Board of Directors

Admiral Robert J. Natter	Tony Bellas	Andrew N. Liveris AO	Zhanna Golodryga	Robert Cooper	Jean Oelwang	Daniel Akerson	Ron Edmonds
Chairman &	Deputy Chairman &	Non-Executive Director	Non-Executive Director	Non-Executive Director	Non-Executive Director	Non-Executive Director	Non-Executive Director
Non-Executive Director	Non-Executive Director

Key leadership and technical experience:

ASX: NVX Nasdaq: NVX OTCQX: NVNXF	5